Investor Relations

Investor Relations

The information transmitted, including any attachments, is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited, and all liability arising therefrom is disclaimed. If you received this in error, please contact the sender and delete the material from any computer.
CORPORATE GOVERNANCE - CODE OF CONDUCT
Parabolic Drugs Limited (Parabolic) is committed to achieve the best standards of Corporate Governance through complete transparency in its dealings with the management, associate companies or other third parties. Parabolic is not only committed for adherence with Corporate Governance, but also with all other regulatory requirements whether Corporate Laws or any other economic or social laws. The management of Parabolic understands its accountability and responsibility towards its shareholders and investors, regulatory authorities and also for other sections of the society.
Click Here to download Code of Conduct
Corporate Governance Reports for the Financial Year 2018-19
Corporate Governance Report 30.09.18
Corporate Governance Report for the quarter year ended 30.06.2018
Corporate Governance Report for the quarter ended on 3oth March 2018
Corporate Governance Reports for the Financial Year 2017-18
Corporate Governance Report for the quarter ended on 31st December 2017
Corporate Governance Report for the quarter ended on 30th September 2017
Corporate Governance Report for the quarter ended on 30th June 2017
Corporate Governance Reports for the Financial Year 2016-17
Corporate Governance Report for the quarter ended on 31-Mar-2017
Corporate Governance Report for the quarter ended on 31-Dec-2016
Corporate Governance Report for the quarter ended on 30-Sept-2016
Corporate Governance Report for the quarter ended on 30-Jun-2016
LATEST FINANCIAL STATEMENTS
FY 2018-2019
Financial Results for the quarter year ended 31 Dec 2018
Parabolic Drugs Limited - Quarterly results for 30.09.2018
Financial Results for the quarter year ended 30.06.2018
Financial Results for the quarter year ended 31.03.2018
FY 2017-2018
Financial Results for the Quarter ended on 31st December 2017 (unaudited)
Financial Results for the Quarter ended on 30th September 2017
Financial Results for the Quarter ended on 30th June 2017(unaudited)
Financial Results for the Quarter ended on 31st March 2017(Audited)
FY 2016-2017
Financial Results for the Quarter ended on 31st December 2016(unaudited)
Financial Results for the Quarter ended on 30th September 2016(unaudited)
Financial Results for the Quarter ended on 30th June 2016(unaudited)
Financial Results for the Quarter ended on 31st March 2016(Audited)
FY 2015-2016
Financial Results for the Quarter ended on 31st December 2015(Unaudited)
Financial Results for the Quarter ended on 30th September 2015(Unaudited)
Financial Results for the Quarter ended on 30th June 2015(Unaudited)
FY 2014-2015
Financial Results for the Quarter ended on 31st March 2015(Audited)
Financial Results for the Quarter ended on 31st December 2014(Unaudited)
Financial Results for the Quarter ended on 30th September 2014(Unaudited)
Financial Results for the Quarter ended on 30 June, 2014(Unaudited)
FY 2013-2014
Financial Results for the Quarter and Year ended on 31st March, 2014(Audited)
Financial Results for the Quarter ended on 31st December,2013(Unaudited)
Financial Results for the Quarter ended on 30th September,2013(Unaudited)
Financial Results for the Quarter ended on 30th June,2013
FY 2012-2013
Financial Results for the Quarter and year ended on 31st March,2013(Audited)
Financial Results for the Quarter ended on 31st December,2012(Unaudited)
Financial Results for the Quarter ended on 30th September,2012(Unaudited)
Financial Results for the Quarter ended on 30th June,2012(Unaudited)
FY 2011-2012
Financial Results for the Quarter ended on 31st March,2012(Unaudited)
Financial Results for the Quarter ended on 31st December,2011(Unaudited)
Financial Results for the Quarter ended on 30th September,2011(Unaudited)
Financial Results for the Quarter ended on 30th June,2011(Unaudited)
Financial Results for the Quarter ended on 30th June,2010(Unaudited)
ANNUAL ACCOUNTS OF SUBSIDIARY
Ziven Lifesciences Limited : Annual accounts for the financial Year
Annual accounts for the financial Year 16-17
Annual accounts for the financial Year 15-16
Annual accounts for the financial Year 14-15
Parabolic Research Labs Limited : Annual Reports for Financial Year
Parabolic Research Labs Limited 16-17
Parabolic Research Labs Limited 15-16
Parabolic Research Labs Limited 14-15

KEY FINANCIAL INDICATORS


TRACK US ON THE STOCK MARKET

The Equity shares of the company are listed on the two Stock Exchanges:


Investor Relations and Compliance Officer

Mr. Ashok Kumar Jindal (Chief Financial Officer)

email: ashok.jindal@parabolicdrugs.com